Sales decline 16.04% to Rs 39.30 crore
Net Loss of Bafna Pharmaceuticals reported to Rs 2.01 crore in the quarter ended March 2014 as against net loss of Rs 0.66 crore during the previous quarter ended March 2013. Sales declined 16.04% to Rs 39.30 crore in the quarter ended March 2014 as against Rs 46.81 crore during the previous quarter ended March 2013.For the full year,net profit declined 65.46% to Rs 1.34 crore in the year ended March 2014 as against Rs 3.88 crore during the previous year ended March 2013. Sales rose 6.22% to Rs 177.54 crore in the year ended March 2014 as against Rs 167.14 crore during the previous year ended March 2013.
Powered by Capital Market - Live News